BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10393323)

  • 1. Function of the propeptide region in recombinant expression of active procathepsin L in Escherichia coli.
    Ogino T; Kaji T; Kawabata M; Satoh K; Tomoo K; Ishida T; Yamazaki H; Ishidoh K; Kominami E
    J Biochem; 1999 Jul; 126(1):78-83. PubMed ID: 10393323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of full-length human procathepsin L cDNA in Escherichia coli and refolding of the expression product.
    Dolinar M; Maganja DB; Turk V
    Biol Chem Hoppe Seyler; 1995 Jun; 376(6):385-8. PubMed ID: 7576233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity and deletion analysis of recombinant human cathepsin L expressed in Escherichia coli.
    Smith SM; Gottesman MM
    J Biol Chem; 1989 Dec; 264(34):20487-95. PubMed ID: 2684978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocatalytic processing of recombinant human procathepsin L. Contribution of both intermolecular and unimolecular events in the processing of procathepsin L in vitro.
    Ménard R; Carmona E; Takebe S; Dufour E; Plouffe C; Mason P; Mort JS
    J Biol Chem; 1998 Feb; 273(8):4478-84. PubMed ID: 9468501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The slow-binding inhibition of cathepsin K by its propeptide.
    Billington CJ; Mason P; Magny MC; Mort JS
    Biochem Biophys Res Commun; 2000 Oct; 276(3):924-9. PubMed ID: 11027570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning, expression and characterisation of murine procathepsin E.
    Tatnell PJ; Lees WE; Kay J
    FEBS Lett; 1997 May; 408(1):62-6. PubMed ID: 9180269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The crystal structure of human procathepsin K.
    LaLonde JM; Zhao B; Janson CA; D'Alessio KJ; McQueney MS; Orsini MJ; Debouck CM; Smith WW
    Biochemistry; 1999 Jan; 38(3):862-9. PubMed ID: 9893980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases.
    Carmona E; Dufour E; Plouffe C; Takebe S; Mason P; Mort JS; Ménard R
    Biochemistry; 1996 Jun; 35(25):8149-57. PubMed ID: 8679567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular insight into propeptide-protein interactions in cathepsins L and O.
    Reif MM; Mach L; Oostenbrink C
    Biochemistry; 2012 Oct; 51(43):8636-53. PubMed ID: 23009386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysine-based structure in the proregion of procathepsin L is the recognition site for mannose phosphorylation.
    Cuozzo JW; Tao K; Wu QL; Young W; Sahagian GG
    J Biol Chem; 1995 Jun; 270(26):15611-9. PubMed ID: 7797559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of Ala205 on the specificity of cathepsin L produced by dextran sulfate assisted activation of the recombinant proenzyme.
    Barlic-Maganja D; Dolinar M; Turk V
    Biol Chem; 1998 Dec; 379(12):1449-52. PubMed ID: 9894813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein inhibitors form complexes with procathepsin L and augment cleavage of the propeptide.
    Majerle A; Jerala R
    Arch Biochem Biophys; 2003 Sep; 417(1):53-8. PubMed ID: 12921779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folding and activation of human procathepsin S from inclusion bodies produced in Escherichia coli.
    Kopitar G; Dolinar M; Strukelj B; Pungercar J; Turk V
    Eur J Biochem; 1996 Mar; 236(2):558-62. PubMed ID: 8612629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human procathepsin S is capable of autocatalytic processing at neutral pH in the presence of glycosaminoglycans.
    Vasiljeva O; Dolinar M; Pungercar JR; Turk V; Turk B
    FEBS Lett; 2005 Feb; 579(5):1285-90. PubMed ID: 15710427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized folding and activation of recombinant procathepsin L and S produced in Escherichia coli.
    Kramer G; Paul A; Kreusch A; Schüler S; Wiederanders B; Schilling K
    Protein Expr Purif; 2007 Jul; 54(1):147-56. PubMed ID: 17391985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pH-dependent membrane association of procathepsin L is mediated by a 9-residue sequence within the propeptide.
    McIntyre GF; Godbold GD; Erickson AH
    J Biol Chem; 1994 Jan; 269(1):567-72. PubMed ID: 8276852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of in vitro folding conditions for procathepsin S and cathepsin S using fractional factorial screens.
    Tobbell DA; Middleton BJ; Raines S; Needham MR; Taylor IW; Beveridge JY; Abbott WM
    Protein Expr Purif; 2002 Mar; 24(2):242-54. PubMed ID: 11858719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated refolding of subtilisin BPN' by tertiary-structure-forming mutants of its propeptide.
    Kojima S; Yanai H; Miura K
    J Biochem; 2001 Oct; 130(4):471-4. PubMed ID: 11574065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric procathepsin E and progastricsin from guinea pig. Purification, molecular cloning of cDNAs, and characterization of enzymatic properties, with special reference to procathepsin E.
    Kageyama T; Ichinose M; Tsukada S; Miki K; Kurokawa K; Koiwai O; Tanji M; Yakabe E; Athauda SB; Takahashi K
    J Biol Chem; 1992 Aug; 267(23):16450-9. PubMed ID: 1644829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solubility of proteins isolated from inclusion bodies is enhanced by fusion to maltose-binding protein or thioredoxin.
    Sachdev D; Chirgwin JM
    Protein Expr Purif; 1998 Feb; 12(1):122-32. PubMed ID: 9473466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.